Medications

Latest obesity drug not cost-effective for adolescents

Among today's obesity drugs, Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers has found that the trendy obesity drug is not cost-effective at its current price.

Psychology & Psychiatry

Study examines opioid agonist therapy use in Medicare patients

Few Medicare enrollees appear to be receiving buprenorphine-naloxone, the only opioid agonist therapy for opioid addiction available through Medicare Part D prescription drug coverage, according to a study published online ...

Arthritis & Rheumatism

Patients grapple with high cost of arthritis medications

The first national investigation of Medicare coverage of biologic disease modifying drugs (DMARDs) found that in starting a single biologic DMARD, patients face more than $2,700 in copayments each year before receiving relief ...

page 2 from 11